These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 20406628
1. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine. Kitaichi Y, Inoue T, Nakagawa S, Boku S, Izumi T, Koyama T. Eur J Pharmacol; 2010 Jul 10; 637(1-3):77-82. PubMed ID: 20406628 [Abstract] [Full Text] [Related]
3. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex. Rollema H, Wilson GG, Lee TC, Folgering JH, Flik G. Neurochem Int; 2011 Jan 10; 58(1):78-84. PubMed ID: 21056607 [Abstract] [Full Text] [Related]
8. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats. Izumi T, Iwamoto N, Kitaichi Y, Kato A, Inoue T, Koyama T. Eur J Pharmacol; 2007 Jun 22; 565(1-3):105-12. PubMed ID: 17400208 [Abstract] [Full Text] [Related]
11. Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats. Kitaichi Y, Inoue T, Izumi T, Nakagawa S, Kato A, Koyama T. Eur J Pharmacol; 2005 Sep 27; 520(1-3):37-42. PubMed ID: 16153636 [Abstract] [Full Text] [Related]
12. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. Aubin N, Barneoud P, Carter C, Caille D, Sontag N, Marc C, Lolivier J, Gardes A, Perron C, Le Kim A, Charieras T, Pandini M, Burnier P, Puech F, Jegham S, George P, Scatton B, Curet O. J Pharmacol Exp Ther; 2004 Sep 27; 310(3):1171-82. PubMed ID: 15178694 [Abstract] [Full Text] [Related]
13. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor. Hewton R, Salem A, Irvine RJ. Clin Exp Pharmacol Physiol; 2007 Oct 27; 34(10):1051-7. PubMed ID: 17714093 [Abstract] [Full Text] [Related]
14. Modification of dopamine release by selective inhibitors of MAO-B. Finberg JP, Lamensdorf I, Armoni T. Neurobiology (Bp); 2000 Oct 27; 8(2):137-42. PubMed ID: 11061211 [Abstract] [Full Text] [Related]
15. Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex. Murata M, Katagiri N, Ishida K, Abe K, Ishikawa M, Utsunomiya I, Hoshi K, Miyamoto K, Taguchi K. Brain Res; 2009 May 07; 1269():40-6. PubMed ID: 19285043 [Abstract] [Full Text] [Related]
18. Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors. Bergman J, Yasar S, Winger G. Psychopharmacology (Berl); 2001 Dec 07; 159(1):21-30. PubMed ID: 11797065 [Abstract] [Full Text] [Related]
19. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Devoto P, Flore G, Pira L, Longu G, Gessa GL. Eur J Pharmacol; 2004 Mar 08; 487(1-3):105-11. PubMed ID: 15033381 [Abstract] [Full Text] [Related]
20. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity. Yáñez M, Fraiz N, Cano E, Orallo F. Eur J Pharmacol; 2006 Aug 07; 542(1-3):54-60. PubMed ID: 16828740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]